Cystic fibrosis - general review on sinonasal complications and case report

1. Rowe S.M., Miller S., Sorscher E.J. - Cystic fibrosis. N Engl J Med., 2005;352(19):1992-2001.Search in Google Scholar

2. Cystic Fibrosis Foundation Patient Registry 2011 Annual Data Report. Bethesda, MD: Cystic Fibrosis Foundation, 2012.Search in Google Scholar

3. Oomen K.P., April M.M. - Sinonasal manifestations in Cystic fibrosis. Int J Otolaryngol., 2012;2012:789572. doi: 10.1155/2012/789572. Epub 2012 Aug 5.10.1155/2012/789572Search in Google Scholar

4. Brihaye P., Jorissen M., Clement P.A. - Chronic rinosinusistis in cystic fibrosis (mucoviscidosis). Acta Otorhinolaryngol Belg., 1997;51(4):323-337.Search in Google Scholar

5. Steinke J.W., Payne S.C., Chen P.G., Negri J., Stelow E.B., Borish L. - Etiology of nasal polyps in cystic fiborisis: not a unimodal disease. Ann Otol Rhinol Laryngol., 2012;121(9):579-586.Search in Google Scholar

6. Tabor A., Alfirevic Z. - Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagn Ther., 2010;27(1):1–7. doi: 10.1159/000271995. Epub 2009 Dec 24.10.1159/000271995Search in Google Scholar

7. Gentile V.G., Isaacson G. - Patterns of sinusitis in cystic fibrosis. Laryngoscope, 1996;106(8):1005-1009.10.1097/00005537-199608000-00018Search in Google Scholar

8. Shapiro E.D., Milmoe G.J., Wald E.R., Rodnan J.B., Bowen A.D. - Bacteriology of the maxillary sinuses in patients with cystic fibrosis. J Infect Dis., 1982;146(5):589–593.Search in Google Scholar

9. Halvorson D.J., Dupree J.R., Porubsky E.S. - Management of chronic sinusitis in the adult cystic fibrosis patient. Ann Otol Rhinol Laryngol., 1998;107(11 Pt 1):946–952.10.1177/000348949810701108Search in Google Scholar

10. Mak G.K., Henig N.R. - Sinus disease in cystic fibrosis. Clin Rev Allergy Immunol., 2001;21(1):51–63.Search in Google Scholar

11. Moss R.B., King V.V. - Management of sinusitis in cystic fibrosis by endoscopic surgery and serial antimicrobial lavage. Reduction in recurrence requiring surgery. Arch Otolaryngol Head Neck Surg., 1995;121(5):566–572.Search in Google Scholar

12. Godoy J.M., Godoy A.N., Ribalta G., Largo I. - Bacterial pattern in chronic sinusitis and cystic fibrosis. Otolaryngol Head Neck Surg., 2011;145(4):673–676. doi: 10.1177/0194599811407279. Epub 2011 Apr 26.10.1177/0194599811407279Search in Google Scholar

13. Robertson J.M., Friedman E.M., Rubin B.K. - Nasal and sinus disease in cystic fibrosis. Paediatr Respir Rev., 2008;9(3):213–219. doi: 10.1019/j.prrv.2008.04.003. Epub 2008 Jul 31.Search in Google Scholar

14. Van Zele T., Claeys S., Gevaert P., Van Maele G., Holtappels G., Van Cauwenberger P., Bachert C. - Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy, 2006;61(11):1280–1289.10.1111/j.1398-9995.2006.01225.xSearch in Google Scholar

15. Welsh M.J., Smith A.E. - Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell, 1993;73(7):1251–1254.10.1016/0092-8674(93)90353-RSearch in Google Scholar

16. Accurso F.J., Rowe S.M., Clancy J.P., et al. - Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation. N Engl J Med., 2010;363(21):1991–2003. doi: 10.1056/NEJmoa0909825.10.1056/NEJMoa0909825Search in Google Scholar

17. Gan K.H., Veeze H.J., van den Ouweland A., et al. - A cystic fibrosis mutation associated with mild lung disease. N Engl J Med., 1995;333:95–99.Search in Google Scholar

18. Haardt M., Benharouga M., Lechardeur D., Kartner N., Lukacs G.L. - C-terminal truncations destabilize the cystic fibrosis transmembrane conductance regulator without impairing its biogenesis. A novel class of mutation. J Biol Chem., 1999;274(31):21873–21877.Search in Google Scholar

19. Woodworth B.A., Ahn C., Flume P.A., Schlosser R.J. - The delta F508 mutation in cystic fibrosis and impact on sinus development. Am J Rhinol., 2007;21(1):122–127.Search in Google Scholar

20. Nishioka G.J., Cook P.R., McKinsey J.P., Rodriguez F.J. - Paranasal sinus computed tomography scan findings in patients with cystic fibrosis. Otolayngol Head Neck Surg., 1996:114(3):394-399.10.1016/S0194-5998(96)70208-5Search in Google Scholar

21. Fuchs H.J., Borowitz D.S., Christiansen D.H., Morris E.M., Nash M.L., Ramsey B.W., Rosenstein B.J., Smith A.L., Wohl M.E. for the Pulmozyme Study Group - Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. N Engl J Med., 1994;331:637–642.Search in Google Scholar

22. Quan J.M., Tiddens H.A., Sy J.P., McKenzie S.G., Montgomery M.D., Robinson P.J., Wohl M.E., Konstan M.W., Pulmozyme Early Intervention Trial Study Group - A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities. J Pediatr., 2001;139(6):813–820.Search in Google Scholar

23. Harms H.K., Matouk E., Tournier G., von der Hardt H., Weller P.H., Romano L., Heijerman H.G., FitzGerald M.X., Richard D., Strandvik B., Kolbe J., Kraemer R., Michalsen H. - Multicenter, open-label study of recombinant human DNase in cystic fibrosis patients with moderate lung disease. DNase International Study Group. Pediatr Pulmonol., 1998;26(3):155–161.Search in Google Scholar

24. Konstan M.W., Schluchter M.D., Xue W., Davis P.B. - Clinical use of Ibuprofen is associated with slower FEV1 decline in children with cystic fibrosis. Am J Respir Crit Care Med., 2007;176(11):1084–1089.Search in Google Scholar

25. Lindstrom D.R., Conley S.F., Splaingard M.L., Gershan W.M. - Ibuprofen therapy and nasal polyposis in cystic fibrosis patients. J Otolaryngol., 2007;36(5):309–314.Search in Google Scholar

26. Suzuki H., Shimomura A., Ikeda K., Furukawa M., Oshima T., Takasaka T. - Inhibitory effect of macrolides on interleukin-8 secretion from cultured human nasal epithelial cells. Laryngoscope, 1997;107(12 Pt 1):1661–1666.10.1097/00005537-199712000-000169396683Search in Google Scholar

27. Saiman L., Marshall B.C., Mayer-Hamblett N., Burns J.L., Quittner A.L., Cibene D.A., Coquillette S., Fieberg A.Y., Accurso F.J., Campbell P.W. 3rd; Macrolide Study Group. - Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: A randomized controlled trial. JAMA, 2003;290(13):1749–1756.10.1001/jama.290.13.174914519709Search in Google Scholar

28. Lim M., Citardi M.J., Leong J.L. - Topical antimicrobials in the management of chronic rhinosinusitis: a systematic review. Am J Rhinol., 2008;22(4):381–389.Search in Google Scholar

29. Kim Chiaw P., Eckford P.D., Bear C.E. - Insights into the mechanisms underlying CFTR channel activity, the molecular basis for cystic fibrosis and strategies for therapy. Essays Biochem., 2011;50(1):233–248. doi: 10.1042/bse0500233.10.1042/bse050023321967060Search in Google Scholar

30. Pettit R.S. - Cystic fibrosis transmembrane conductance regulator-modifying medications: the future of cystic fibrosis treatment. Ann Pharmacother., 2012;46(7-8):1065–1075. doi: 10.1345/aph.1R076. Epub 2012 Jun 26.10.1345/aph.1R07622739718Search in Google Scholar

31. Lewiston N., King V., Umetsu D., Starnes V., Marshall S., Kramer M., Theodore J. - Cystic fibrosis patients who have undergone heart-lung transplantation benefit from maxillary sinus antrostomy and repeated sinus lavage. Transplant Proc., 1991;23(1 Pt 2):1207–1208.Search in Google Scholar

32. Rowe-Jones J.M., Mackay I.S. - Endoscopic sinus surgery in the treatment of cystic fibrosis with nasal polyposis. Laryngoscope, 1996;106(12 Pt 1):1540–1544.10.1097/00005537-199612000-000198948619Search in Google Scholar